News Pharma Industry

After a strong debut, can Medanta sustain gains? Earnings growth, retaining specialists will be key.


Naresh Trehan, CMD, Global Health Limited; courtesy of Medanta

Synopsis

Reasonable valuations, healthy financials, and growing interest of investors in the hospitals segment have worked in favour of Medanta. While the stock isn’t overpriced compared to its peers, its performance will depend on consistent improvement in earnings over the next few quarters. So, what will be the company’s levers of growth?

Last week, Global Health Ltd, the company which operates hospitals under the brand Medanta, made a strong debut on the Indian stock exchanges. Its shares gained 19% on the listing day. At Thursday’s close of INR462.50 per share, the stock is around 38% up from its issue price of INR336. The company’s initial public offering (IPO) had also garnered good interest. It was oversubscribed 9.58 times.Reasonable valuations, healthy financials, and

  • FONT SIZE
  • SAVE
  • PRINT
  • COMMENT

Uh-oh! This is an exclusive story available for selected readers only.

Worry not. You’re just a step away.

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise



Source link

Leave a Comment